Durand-Zaleski Isabelle, Combe Christian, Lang Philippe
Department of Public Health, AP-HP, Henri Mondor Hospital, Paris, France.
Int J Health Care Finance Econ. 2007 Sep;7(2-3):171-83. doi: 10.1007/s10754-007-9025-8.
The major features of ESRD management in France include the predominance of hemodialysis and the resulting competition for dialysis stations. In 2003, the prevalence of ESRD in France was 0.087%. Of the 52,000 ESRD patients, 30,882 were receiving dialysis and 21,233 had functioning renal transplants. The annual expenditure per ESRD patient in 2003 was estimated at euro40,975. Autodialysis, at euro49,133 per patient per year, was much less expensive than dialyzing in-center at either a public or private facility (euro111,006 and euro75,125, respectively). Transplant activity in France has rapidly increased in recent years, reaching 22 donors per million population in 2005.
法国终末期肾病管理的主要特点包括血液透析占主导地位以及由此产生的对透析站的竞争。2003年，法国终末期肾病的患病率为0.087%。在52000例终末期肾病患者中，30882例正在接受透析，21233例拥有功能正常的肾移植。2003年，每位终末期肾病患者的年度支出估计为40975欧元。自我透析每年每位患者花费49133欧元，比在公立或私立机构进行中心透析便宜得多（分别为111006欧元和75125欧元）。近年来，法国的移植活动迅速增加，2005年达到每百万人口22例捐赠者。
